Clinical Trials Directory

Trials / Unknown

UnknownNCT04900584

Optimize Heart Failure Care During TRANSitional Period in Patients With Acute Heart Failure.

A Prospective Randomized Multicenter Controlled Study to Optimize Heart Failure Care During TRANSitional Period in Patients With Acute Heart Failure With Reduced Ejection Fraction.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,009 (actual)
Sponsor
Wonju Severance Christian Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The period of about a month after the discharge of acute heart failure patients is defined as a transition time. During this period, the patient has a high mortality rate and a readmission rate because the patient is not stabilized. In the United States and Europe, the readmission rate is more than 25% within 30 days, and the mortality rate within 30 days after discharge is three times that of patients with chronic heart failure. The TRANS-HF is a prospective, randomized, multi-center, controlled study, which enrolls patients with acute heart failure with reduced ejection fraction. The objective of TRANS-HF is to improve GAI at six months through three interventions: pre-discharge checklist, heart failure education, and telephone monitoring before the first outpatient visit.

Conditions

Interventions

TypeNameDescription
OTHERChecklistChecklist of guideline-based treatment before discharge
OTHEREducationHeart failure education before discharge
OTHERTelephone monitoringTelephone monitoring after discharge

Timeline

Start date
2020-06-23
Primary completion
2022-10-31
Completion
2023-02-28
First posted
2021-05-25
Last updated
2022-06-01

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04900584. Inclusion in this directory is not an endorsement.